Timing of MMR Vaccination After Steroid Therapy
For high-dose systemic steroids (≥2 mg/kg/day or ≥20 mg/day prednisone equivalent) given for ≥14 days, wait at least 1 month after stopping steroids before administering MMR vaccine. 1
Decision Algorithm Based on Steroid Exposure
High-Dose, Prolonged Therapy (≥14 days)
If the patient received systemic corticosteroids at doses equivalent to:
- ≥2 mg/kg/day prednisone, OR
- ≥20 mg total daily dose
- Given daily or on alternate days for ≥14 days
Action: Wait at least 1 month after cessation of steroid therapy before giving MMR 1
High-Dose, Short-Term Therapy (<14 days)
If the patient received the same high doses (≥2 mg/kg/day or ≥20 mg/day) but for <14 days:
Action: MMR can generally be given immediately after stopping steroids, though some experts prefer waiting 2 weeks 1
Low-to-Moderate Dose or Special Routes
MMR vaccination is NOT contraindicated and requires no waiting period when steroids are given as:
- Short-term (<14 days) low-to-moderate dose
- Low-to-moderate dose on alternate days (any duration)
- Physiologic replacement doses
- Topical (skin/eyes), aerosol, or intra-articular injection
- Unless there is clinical or laboratory evidence of systemic immunosuppression 1
Critical Caveats
Prolonged topical/aerosol steroids: If extensive topical, aerosol, or local corticosteroid therapy causes clinical or laboratory evidence of systemic immunosuppression, wait at least 1 month after cessation 1
Underlying immunosuppressive disease: Do not give MMR to patients who have a disease that itself suppresses immunity AND are receiving corticosteroids (systemic or local), regardless of dose or duration 1
Rationale
The ACIP guidelines 1 establish these thresholds based on the immunosuppressive effects of corticosteroids on live virus vaccine safety and efficacy. The 1-month waiting period after high-dose prolonged therapy allows immune reconstitution to minimize risk of vaccine-associated infection while maximizing vaccine response. The dose threshold of 2 mg/kg/day or 20 mg/day represents the level at which most clinicians consider immunosuppression clinically significant enough to raise safety concerns with live virus vaccines.
For short courses of high-dose steroids (<14 days), immediate vaccination is generally acceptable because brief exposure is less likely to cause sustained immunosuppression, though a 2-week delay provides an additional safety margin if preferred.